APO Research
Talk to an analyst

APO RESEARCH · REPORT

Soft Capsules Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Soft Capsules Drugs Market Analysis and Forecast 2026-2032

2 January 2026200 pages

Choose your research edition.

Industry ResearchSoft Capsules Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Soft Capsules Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Soft Capsules Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soft Capsules Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Soft Capsules Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Soft Capsules Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Soft Capsules Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Soft Capsules Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Soft Capsules Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Soft Capsules Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Soft Capsules Drugs include GSK, A&Z Pharmaceutical, Atrium Innovations, Blackmores, Boehringer Ingelheim, By-health, Chiesi, Nature Made and Sumitomo Dainippon, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Soft Capsules Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Soft Capsules Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Soft Capsules Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Soft Capsules Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Soft Capsules Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Soft Capsules Drugs revenue, projected growth trends, production technology, application and end-user industry.

Soft Capsules Drugs Segment by Company

GSK

A&Z Pharmaceutical

Atrium Innovations

Blackmores

Boehringer Ingelheim

By-health

Chiesi

Nature Made

Sumitomo Dainippon

The Clorox Company

Vertex

AstraZeneca

Roche

Merck

Novartis

Teva

Abbott

Soft Capsules Drugs Segment by Type

Liquid Core Drugs

Semi-solid Core Drugs

Soft Capsules Drugs Segment by Application

Hospital Pharmacy

Retail Pharmacy

Soft Capsules Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soft Capsules Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soft Capsules Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soft Capsules Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Soft Capsules Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Soft Capsules Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Soft Capsules Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Soft Capsules Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liquid Core Drugs Major Player Table 3. Semi-solid Core Drugs Major Player Table 4. Global Soft Capsules Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacy Major Player Table 6. Retail Pharmacy Major Player Table 7. Soft Capsules Drugs Industry Trends Table 8. Soft Capsules Drugs Industry Drivers Table 9. Soft Capsules Drugs Industry Opportunities and Challenges Table 10. Soft Capsules Drugs Industry Restraints Table 11. Global Soft Capsules Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Soft Capsules Drugs Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Soft Capsules Drugs Market Share by Region (2021-2026) Table 14. Global Soft Capsules Drugs Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Soft Capsules Drugs Market Share by Region (2027-2032) Table 16. Global Soft Capsules Drugs Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Soft Capsules Drugs Revenue Market Share by Players (2021-2026) Table 18. Global Soft Capsules Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Soft Capsules Drugs Key Players Headquarters & Area Served Table 20. Global Soft Capsules Drugs Players, Product Type & Application Table 21. Global Soft Capsules Drugs Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Soft Capsules Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Soft Capsules Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Soft Capsules Drugs Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Soft Capsules Drugs Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Soft Capsules Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Soft Capsules Drugs Revenue Market Share by Type (2027-2032) Table 29. Global Soft Capsules Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Soft Capsules Drugs Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Soft Capsules Drugs Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Soft Capsules Drugs Revenue Market Share by Application (2021-2026) Table 33. Global Soft Capsules Drugs Revenue Market Share by Application (2027-2032) Table 34. GSK Company Information Table 35. GSK Business Overview Table 36. GSK Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. GSK Soft Capsules Drugs Product Portfolio Table 38. GSK Recent Development Table 39. A&Z Pharmaceutical Company Information Table 40. A&Z Pharmaceutical Business Overview Table 41. A&Z Pharmaceutical Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. A&Z Pharmaceutical Soft Capsules Drugs Product Portfolio Table 43. A&Z Pharmaceutical Recent Development Table 44. Atrium Innovations Company Information Table 45. Atrium Innovations Business Overview Table 46. Atrium Innovations Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Atrium Innovations Soft Capsules Drugs Product Portfolio Table 48. Atrium Innovations Recent Development Table 49. Blackmores Company Information Table 50. Blackmores Business Overview Table 51. Blackmores Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Blackmores Soft Capsules Drugs Product Portfolio Table 53. Blackmores Recent Development Table 54. Boehringer Ingelheim Company Information Table 55. Boehringer Ingelheim Business Overview Table 56. Boehringer Ingelheim Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Boehringer Ingelheim Soft Capsules Drugs Product Portfolio Table 58. Boehringer Ingelheim Recent Development Table 59. By-health Company Information Table 60. By-health Business Overview Table 61. By-health Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. By-health Soft Capsules Drugs Product Portfolio Table 63. By-health Recent Development Table 64. Chiesi Company Information Table 65. Chiesi Business Overview Table 66. Chiesi Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Chiesi Soft Capsules Drugs Product Portfolio Table 68. Chiesi Recent Development Table 69. Nature Made Company Information Table 70. Nature Made Business Overview Table 71. Nature Made Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Nature Made Soft Capsules Drugs Product Portfolio Table 73. Nature Made Recent Development Table 74. Sumitomo Dainippon Company Information Table 75. Sumitomo Dainippon Business Overview Table 76. Sumitomo Dainippon Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Sumitomo Dainippon Soft Capsules Drugs Product Portfolio Table 78. Sumitomo Dainippon Recent Development Table 79. The Clorox Company Company Information Table 80. The Clorox Company Business Overview Table 81. The Clorox Company Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. The Clorox Company Soft Capsules Drugs Product Portfolio Table 83. The Clorox Company Recent Development Table 84. Vertex Company Information Table 85. Vertex Business Overview Table 86. Vertex Soft Capsules Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Vertex Soft Capsules Drugs Product Portfolio Table 88. Vertex Recent Development Table 89. AstraZeneca Company Information Table 90. AstraZeneca Business Overview Table 91. AstraZeneca Soft Capsules Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. AstraZeneca Soft Capsules Drugs Product Portfolio Table 93. AstraZeneca Recent Development Table 94. Roche Company Information Table 95. Roche Business Overview Table 96. Roche Soft Capsules Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Roche Soft Capsules Drugs Product Portfolio Table 98. Roche Recent Development Table 99. Merck Company Information Table 100. Merck Business Overview Table 101. Merck Soft Capsules Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Merck Soft Capsules Drugs Product Portfolio Table 103. Merck Recent Development Table 104. Novartis Company Information Table 105. Novartis Business Overview Table 106. Novartis Soft Capsules Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Novartis Soft Capsules Drugs Product Portfolio Table 108. Novartis Recent Development Table 109. Teva Company Information Table 110. Teva Business Overview Table 111. Teva Soft Capsules Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Teva Soft Capsules Drugs Product Portfolio Table 113. Teva Recent Development Table 114. Abbott Company Information Table 115. Abbott Business Overview Table 116. Abbott Soft Capsules Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Abbott Soft Capsules Drugs Product Portfolio Table 118. Abbott Recent Development Table 119. North America Soft Capsules Drugs Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Soft Capsules Drugs Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Soft Capsules Drugs Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Soft Capsules Drugs Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Soft Capsules Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Soft Capsules Drugs Revenue by Country (2021-2026) & (US$ Million) Table 125. North America Soft Capsules Drugs Revenue by Country (US$ Million) & (2027-2032) Table 126. Europe Soft Capsules Drugs Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Soft Capsules Drugs Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Soft Capsules Drugs Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Soft Capsules Drugs Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Soft Capsules Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Soft Capsules Drugs Revenue by Country (2021-2026) & (US$ Million) Table 132. Europe Soft Capsules Drugs Revenue by Country (US$ Million) & (2027-2032) Table 133. China Soft Capsules Drugs Revenue by Type (2021-2026) & (US$ Million) Table 134. China Soft Capsules Drugs Revenue by Type (2027-2032) & (US$ Million) Table 135. China Soft Capsules Drugs Revenue by Application (2021-2026) & (US$ Million) Table 136. China Soft Capsules Drugs Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Soft Capsules Drugs Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Soft Capsules Drugs Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Soft Capsules Drugs Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Soft Capsules Drugs Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Soft Capsules Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Soft Capsules Drugs Revenue by Region (US$ Million) & (2021-2026) Table 143. Asia Soft Capsules Drugs Revenue by Region (US$ Million) & (2027-2032) Table 144. SAMEA Soft Capsules Drugs Revenue by Type (2021-2026) & (US$ Million) Table 145. SAMEA Soft Capsules Drugs Revenue by Type (2027-2032) & (US$ Million) Table 146. SAMEA Soft Capsules Drugs Revenue by Application (2021-2026) & (US$ Million) Table 147. SAMEA Soft Capsules Drugs Revenue by Application (2027-2032) & (US$ Million) Table 148. SAMEA Soft Capsules Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. SAMEA Soft Capsules Drugs Revenue by Country (2021-2026) & (US$ Million) Table 150. SAMEA Soft Capsules Drugs Revenue by Country (US$ Million) & (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Soft Capsules Drugs Image Figure 2. Global Soft Capsules Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Soft Capsules Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liquid Core Drugs Image Figure 5. Semi-solid Core Drugs Image Figure 6. Global Soft Capsules Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Soft Capsules Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacy Image Figure 9. Retail Pharmacy Image Figure 10. Global Soft Capsules Drugs Market Size (US$ Million) & (2021-2032) Figure 11. Global Soft Capsules Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Soft Capsules Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Soft Capsules Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Soft Capsules Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Soft Capsules Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Soft Capsules Drugs Revenue Market Share by Type (2021-2032) Figure 18. Global Soft Capsules Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Soft Capsules Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Soft Capsules Drugs Revenue Market Share by Application (2021-2032) Figure 21. North America Soft Capsules Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Soft Capsules Drugs Revenue Share by Type (2021-2032) Figure 23. North America Soft Capsules Drugs Revenue Share by Application (2021-2032) Figure 24. North America Soft Capsules Drugs Revenue Share by Country (2021-2032) Figure 25. United States Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Soft Capsules Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Soft Capsules Drugs Revenue Share by Type (2021-2032) Figure 30. Europe Soft Capsules Drugs Revenue Share by Application (2021-2032) Figure 31. Europe Soft Capsules Drugs Revenue Share by Country (2021-2032) Figure 32. Germany Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Soft Capsules Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Soft Capsules Drugs Revenue Share by Type (2021-2032) Figure 42. China Soft Capsules Drugs Revenue Share by Application (2021-2032) Figure 43. Asia Soft Capsules Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Soft Capsules Drugs Revenue Share by Type (2021-2032) Figure 45. Asia Soft Capsules Drugs Revenue Share by Application (2021-2032) Figure 46. Asia Soft Capsules Drugs Revenue Share by Region (2021-2032) Figure 47. Japan Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Soft Capsules Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Soft Capsules Drugs Revenue Share by Type (2021-2032) Figure 55. SAMEA Soft Capsules Drugs Revenue Share by Application (2021-2032) Figure 56. SAMEA Soft Capsules Drugs Revenue Share by Country (2021-2032) Figure 57. Brazil Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Soft Capsules Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Core Drugs
  • Semi-solid Core Drugs
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • GSK
  • A&Z Pharmaceutical
  • Atrium Innovations
  • Blackmores
  • Boehringer Ingelheim
  • By-health
  • Chiesi
  • Nature Made
  • Sumitomo Dainippon
  • The Clorox Company
  • Vertex
  • AstraZeneca
  • Roche
  • Merck
  • Novartis
  • Teva
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Soft Capsules Drugs Market by Type
  3. 1.2.1 Global Soft Capsules Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid Core Drugs
  5. 1.2.3 Semi-solid Core Drugs
  6. 1.3 Soft Capsules Drugs Market by Application
  7. 1.3.1 Global Soft Capsules Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacy
  9. 1.3.3 Retail Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Soft Capsules Drugs Market Dynamics
  1. 2.1 Soft Capsules Drugs Industry Trends
  2. 2.2 Soft Capsules Drugs Industry Drivers
  3. 2.3 Soft Capsules Drugs Industry Opportunities and Challenges
  4. 2.4 Soft Capsules Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Soft Capsules Drugs Market Perspective (2021-2032)
  2. 3.2 Global Soft Capsules Drugs Growth Trends by Region
  3. 3.2.1 Global Soft Capsules Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Soft Capsules Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Soft Capsules Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Soft Capsules Drugs Revenue by Players
  2. 4.1.1 Global Soft Capsules Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Soft Capsules Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Soft Capsules Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Soft Capsules Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Soft Capsules Drugs Players, Product Type & Application
  8. 4.5 Global Soft Capsules Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Soft Capsules Drugs Market CR5 and HHI
  11. 4.6.3 2025 Soft Capsules Drugs Tier 1, Tier 2, and Tier 3
5 Soft Capsules Drugs Market Size by Type
  1. 5.1 Global Soft Capsules Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Soft Capsules Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Soft Capsules Drugs Revenue Market Share by Type (2021-2032)
6 Soft Capsules Drugs Market Size by Application
  1. 6.1 Global Soft Capsules Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Soft Capsules Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Soft Capsules Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GSK Soft Capsules Drugs Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 A&Z Pharmaceutical
  8. 7.2.1 A&Z Pharmaceutical Company Information
  9. 7.2.2 A&Z Pharmaceutical Business Overview
  10. 7.2.3 A&Z Pharmaceutical Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 A&Z Pharmaceutical Soft Capsules Drugs Product Portfolio
  12. 7.2.5 A&Z Pharmaceutical Recent Developments
  13. 7.3 Atrium Innovations
  14. 7.3.1 Atrium Innovations Company Information
  15. 7.3.2 Atrium Innovations Business Overview
  16. 7.3.3 Atrium Innovations Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Atrium Innovations Soft Capsules Drugs Product Portfolio
  18. 7.3.5 Atrium Innovations Recent Developments
  19. 7.4 Blackmores
  20. 7.4.1 Blackmores Company Information
  21. 7.4.2 Blackmores Business Overview
  22. 7.4.3 Blackmores Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Blackmores Soft Capsules Drugs Product Portfolio
  24. 7.4.5 Blackmores Recent Developments
  25. 7.5 Boehringer Ingelheim
  26. 7.5.1 Boehringer Ingelheim Company Information
  27. 7.5.2 Boehringer Ingelheim Business Overview
  28. 7.5.3 Boehringer Ingelheim Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Boehringer Ingelheim Soft Capsules Drugs Product Portfolio
  30. 7.5.5 Boehringer Ingelheim Recent Developments
  31. 7.6 By-health
  32. 7.6.1 By-health Company Information
  33. 7.6.2 By-health Business Overview
  34. 7.6.3 By-health Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 By-health Soft Capsules Drugs Product Portfolio
  36. 7.6.5 By-health Recent Developments
  37. 7.7 Chiesi
  38. 7.7.1 Chiesi Company Information
  39. 7.7.2 Chiesi Business Overview
  40. 7.7.3 Chiesi Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Chiesi Soft Capsules Drugs Product Portfolio
  42. 7.7.5 Chiesi Recent Developments
  43. 7.8 Nature Made
  44. 7.8.1 Nature Made Company Information
  45. 7.8.2 Nature Made Business Overview
  46. 7.8.3 Nature Made Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nature Made Soft Capsules Drugs Product Portfolio
  48. 7.8.5 Nature Made Recent Developments
  49. 7.9 Sumitomo Dainippon
  50. 7.9.1 Sumitomo Dainippon Company Information
  51. 7.9.2 Sumitomo Dainippon Business Overview
  52. 7.9.3 Sumitomo Dainippon Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sumitomo Dainippon Soft Capsules Drugs Product Portfolio
  54. 7.9.5 Sumitomo Dainippon Recent Developments
  55. 7.10 The Clorox Company
  56. 7.10.1 The Clorox Company Company Information
  57. 7.10.2 The Clorox Company Business Overview
  58. 7.10.3 The Clorox Company Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 The Clorox Company Soft Capsules Drugs Product Portfolio
  60. 7.10.5 The Clorox Company Recent Developments
  61. 7.11 Vertex
  62. 7.11.1 Vertex Company Information
  63. 7.11.2 Vertex Business Overview
  64. 7.11.3 Vertex Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Vertex Soft Capsules Drugs Product Portfolio
  66. 7.11.5 Vertex Recent Developments
  67. 7.12 AstraZeneca
  68. 7.12.1 AstraZeneca Company Information
  69. 7.12.2 AstraZeneca Business Overview
  70. 7.12.3 AstraZeneca Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  71. 7.12.4 AstraZeneca Soft Capsules Drugs Product Portfolio
  72. 7.12.5 AstraZeneca Recent Developments
  73. 7.13 Roche
  74. 7.13.1 Roche Company Information
  75. 7.13.2 Roche Business Overview
  76. 7.13.3 Roche Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Roche Soft Capsules Drugs Product Portfolio
  78. 7.13.5 Roche Recent Developments
  79. 7.14 Merck
  80. 7.14.1 Merck Company Information
  81. 7.14.2 Merck Business Overview
  82. 7.14.3 Merck Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Merck Soft Capsules Drugs Product Portfolio
  84. 7.14.5 Merck Recent Developments
  85. 7.15 Novartis
  86. 7.15.1 Novartis Company Information
  87. 7.15.2 Novartis Business Overview
  88. 7.15.3 Novartis Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Novartis Soft Capsules Drugs Product Portfolio
  90. 7.15.5 Novartis Recent Developments
  91. 7.16 Teva
  92. 7.16.1 Teva Company Information
  93. 7.16.2 Teva Business Overview
  94. 7.16.3 Teva Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Teva Soft Capsules Drugs Product Portfolio
  96. 7.16.5 Teva Recent Developments
  97. 7.17 Abbott
  98. 7.17.1 Abbott Company Information
  99. 7.17.2 Abbott Business Overview
  100. 7.17.3 Abbott Soft Capsules Drugs Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Abbott Soft Capsules Drugs Product Portfolio
  102. 7.17.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Soft Capsules Drugs Revenue (2021-2032)
  2. 8.2 North America Soft Capsules Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Soft Capsules Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Soft Capsules Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Soft Capsules Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Soft Capsules Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Soft Capsules Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Soft Capsules Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Soft Capsules Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Soft Capsules Drugs Revenue by Country
  11. 8.6.1 North America Soft Capsules Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Soft Capsules Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Soft Capsules Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Soft Capsules Drugs Revenue (2021-2032)
  2. 9.2 Europe Soft Capsules Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Soft Capsules Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Soft Capsules Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Soft Capsules Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Soft Capsules Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Soft Capsules Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Soft Capsules Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Soft Capsules Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Soft Capsules Drugs Revenue by Country
  11. 9.6.1 Europe Soft Capsules Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Soft Capsules Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Soft Capsules Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Soft Capsules Drugs Revenue (2021-2032)
  2. 10.2 China Soft Capsules Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Soft Capsules Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Soft Capsules Drugs Revenue by Type (2027-2032)
  5. 10.3 China Soft Capsules Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Soft Capsules Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Soft Capsules Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Soft Capsules Drugs Revenue by Application (2027-2032)
  9. 10.5 China Soft Capsules Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Soft Capsules Drugs Revenue (2021-2032)
  2. 11.2 Asia Soft Capsules Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Soft Capsules Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Soft Capsules Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Soft Capsules Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Soft Capsules Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Soft Capsules Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Soft Capsules Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Soft Capsules Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Soft Capsules Drugs Revenue by Country
  11. 11.6.1 Asia Soft Capsules Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Soft Capsules Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Soft Capsules Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Soft Capsules Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Soft Capsules Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Soft Capsules Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Soft Capsules Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Soft Capsules Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Soft Capsules Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Soft Capsules Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Soft Capsules Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Soft Capsules Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Soft Capsules Drugs Revenue by Country
  11. 12.6.1 SAMEA Soft Capsules Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Soft Capsules Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Soft Capsules Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst